Anti-Microbialvior BioteQ Co (ROCO:6864) Total Payout Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6864 Anti-Microbial Savior BioteQ Co Ltd ROCO:6864
65 GF Score
Price NT$48.60
GF Value NT$83.42
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Anti-Microbialvior BioteQ Co Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Anti-Microbialvior BioteQ Co's current Total Payout Ratio is .

Anti-Microbialvior BioteQ Co Total Payout Ratio Related Terms

Anti-Microbialvior BioteQ Co Total Payout Ratio Historical Data

* Premium members only.

The historical data trend for Anti-Microbialvior BioteQ Co's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anti-Microbialvior BioteQ Co Total Payout Ratio Chart

Anti-Microbialvior BioteQ Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Payout Ratio
Get a 7-Day Free Trial - - - - -

Anti-Microbialvior BioteQ Co Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Total Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ROCO:6864 vs VRTX, REGN, MRNA: Total Payout Ratio Comparison

For the Biotechnology subindustry, Anti-Microbialvior BioteQ Co's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anti-Microbialvior BioteQ Co Total Payout Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anti-Microbialvior BioteQ Co's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Anti-Microbialvior BioteQ Co's Total Payout Ratio falls into.


ROCO:6864
65GF Score
Anti-Microbial Savior BioteQ Co Ltd ROCO:6864
Total Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anti-Microbialvior BioteQ Co Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Anti-Microbialvior BioteQ Co's Total Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (-0 + 360 + -0) / -93.597
=3.85

Anti-Microbialvior BioteQ Co's Total Payout Ratio for the quarter that ended in Jun. 2026 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (-0 + 1.8 + -0) / -41.65
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Anti-Microbialvior BioteQ Co (ROCO:6864) Overvalued in 2026?

Based on GuruFocus' analysis, Anti-Microbialvior BioteQ Co stock appears to be undervalued. The current stock price of NT$48.60 is trading 41.7% below its estimated GF Value™ of NT$83.42. GuruFocus considers Anti-Microbialvior BioteQ Co to be Significantly Undervalued.

Key valuation signals for ROCO:6864:

  • Total Payout Ratio:
  • GF Value™: NT$83.42 vs. price of NT$48.60 (41.7% below fair value)
  • GF Score™: 65/100 with 3 warning signs

No single metric tells the full story. See the ROCO:6864 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Anti-Microbialvior BioteQ Co Business Description

Address No. 6, Siwei 3rd Road, 7th Floor-2, Lingya District, Kaohsiung, TWN, 741
Anti-Microbial Savior BioteQ Co Ltd is engaged in drug research and development as well as development and technology patenting of medical fungi.
65GF Score

Get the complete analysis for ROCO:6864

Total Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$48.60
Price
NT$83.42
GF Value